Literature DB >> 12773168

Human carboxylesterase 1: from drug metabolism to drug discovery.

M R Redinbo1, S Bencharit, P M Potter.   

Abstract

Human carboxylesterase 1 (hCE1) is a serine esterase involved in both drug metabolism and activation, as well as other biological processes. hCE1 catalyses the hydrolysis of heroin and cocaine, and the transesterification of cocaine in the presence of ethanol to the toxic metabolite cocaethylene. We have determined the crystal structures of hCE1 in complex with either the cocaine analogue homatropine or the heroin analogue naloxone. These are the first structures of a human carboxylesterase, and they provide details about narcotic metabolism in humans. hCE1's active site contains rigid and flexible pockets, explaining the enzyme's ability to act both specifically and promiscuously. hCE1 has also been reported to contain cholesteryl ester hydrolase, fatty acyl-CoA hydrolase and acyl-CoA:cholesterol acyltransferase activities, and thus appears to be involved in cholesterol metabolism. Since the enzyme may be useful as a treatment for cocaine overdose, and may afford protection against chemical weapons like Sarin, Soman and VX gas, hCE1 could serve as both a drug and a drug target. Selective hCE1 inhibitors targeted to several sites on the enzyme may also pave the way for novel clinical tools to manage cholesterol homoeostasis in humans.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12773168     DOI: 10.1042/bst0310620

Source DB:  PubMed          Journal:  Biochem Soc Trans        ISSN: 0300-5127            Impact factor:   5.407


  29 in total

1.  The Development of Bacterial Carboxylesterase Biological Recognition Elements for Cocaine Detection.

Authors:  Suhad A Mustafa
Journal:  Mol Biotechnol       Date:  2018-08       Impact factor: 2.695

Review 2.  Carboxylesterase inhibitors.

Authors:  M Jason Hatfield; Philip M Potter
Journal:  Expert Opin Ther Pat       Date:  2011-05-24       Impact factor: 6.674

Review 3.  Protein adducts as biomarkers of exposure to organophosphorus compounds.

Authors:  Judit Marsillach; Lucio G Costa; Clement E Furlong
Journal:  Toxicology       Date:  2012-12-20       Impact factor: 4.221

4.  Lower serum hepcidin and greater parenchymal iron in nonalcoholic fatty liver disease patients with C282Y HFE mutations.

Authors:  James E Nelson; Elizabeth M Brunt; Kris V Kowdley
Journal:  Hepatology       Date:  2012-09-20       Impact factor: 17.425

Review 5.  Iron metabolism in Nonalcoholic Fatty Liver Disease.

Authors:  James E Nelson; Heather Klintworth; Kris V Kowdley
Journal:  Curr Gastroenterol Rep       Date:  2012-02

6.  Stem cell-ness: a "magic marker" for cancer.

Authors:  John P Lahad; Gordon B Mills; Kevin R Coombes
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

Review 7.  The role of human carboxylesterases in drug metabolism: have we overlooked their importance?

Authors:  S Casey Laizure; Vanessa Herring; Zheyi Hu; Kevin Witbrodt; Robert B Parker
Journal:  Pharmacotherapy       Date:  2013-02       Impact factor: 4.705

8.  Undesired versus designed enzymatic cleavage of linkers for liver targeting.

Authors:  Srinivas R Chirapu; Jonathan N Bauman; Heather Eng; Theunis C Goosen; Timothy J Strelevitz; Subhash C Sinha; Robert L Dow; M G Finn
Journal:  Bioorg Med Chem Lett       Date:  2014-01-08       Impact factor: 2.823

9.  Liver prenylated methylated protein methyl esterase is the same enzyme as Sus scrofa carboxylesterase.

Authors:  Onovughode T Oboh; Nazarius S Lamango
Journal:  J Biochem Mol Toxicol       Date:  2008-02       Impact factor: 3.642

10.  The effect of ethanol on oral cocaine pharmacokinetics reveals an unrecognized class of ethanol-mediated drug interactions.

Authors:  Robert B Parker; S Casey Laizure
Journal:  Drug Metab Dispos       Date:  2009-11-17       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.